Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
2minutemedicine.com
16h
Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma
Afami-cel (Tecelra) is the first genetically engineered T-cell receptor therapy for synovial sarcoma Afami-cel demonstrated ...
2minutemedicine.com
18h
Semaglutide reduces heart failure events in patients with preserved ejection fraction
Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene now hurricane
Would-be assassin charged
Penn suspends law professor
Campaign office damaged
Woman dies in 'suicide pod’
Texas AG appeal denied
Calls strike against 'LoL’
US to waive visas for Qatar
InfoWars to be auctioned off
School book bans surge
Briefed on Iranian threats
Study: Myopia on the rise
CA new gun control laws
China conducts ICBM test
Chemical leak in OH county
To cut Atlanta service, jobs
Israel intercepts first missile
Time for COVID, flu shots
Pac-12 sues Mountain West
ISR: Hezbollah leader killed
NYC schools boss retiring
Johnny Cash statue unveiled
X account hacked
Union gets more voting time
Gets 2-yrs for role in fraud
Rioter mistakenly released
Executed by lethal injection
$375M military aid to UKR
‘Trump Train’ jury verdict
Feedback